ABCL compared with TRUP: revenue, margins and what each company keeps, and the suppliers and customers both name

ABCLAbCellera Biologics Inc.

Mkt capRevenueRevenue

TRUPTrupanion, Inc.

Mkt capRevenueRevenue

Compare

ABCLAbCellera Biologics Inc.

TRUPTrupanion, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ABCL1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.4%▲+10.30%×0.67

TRUP

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±11.0%▲+5.85%×0.53

Q2 FY26±13.0%▲+15.46%×1.19

= impliedABCL realized, solidTRUP realized, hatchedOne scale, both sides: full bar = 16%× = |realized| ÷ impliedSource: market data

Q1 FY26

±12.9%

▲+1.42%

×0.11

Feb 13 '26±11.4%▼−13.01%×1.14

ABCLAbCellera Biologics Inc.

11.90▲+6.87%· post 11.92

Mkt cap$3.6BRevenue$4MQ2 FY26Revenue$75MFY25

TRUPTrupanion, Inc.

36.79▲+5.96%· post 36.03

ClosedNov 6 '26

Mkt cap$1.6BRevenue$406MQ3 FY26Revenue$1.4BFY25

Compare

ClosedNov 6 '26

ABCLAbCellera Biologics Inc.

TRUPTrupanion, Inc.

11.90▲+6.87%post 11.92

Price

36.79▲+5.96%post 36.03

$3.6B

Mkt cap

$1.6B

Q2 FY26$4M

Revenue

$406MQ3 FY26

FY25$75M

Revenue

$1.4BFY25

ABCL11.90▲+6.87%vsTRUP36.79▲+5.96%ClosedNov 6 '26